Phase II study of oral S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer

UMIN ID: UMIN000001745

Registered date:03/03/2009

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Locally Advanced Non-Small Cell Lung Cancer
• Date of first enrollment: 2008/09/01
• Target sample size: 40
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Cisplatin+TS-1

Outcome(s)

• Primary Outcome: Response rate
• Secondary Outcome: Adverse events, overall survival, progression-free survival, safty

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: 75years-old
• Gender: Male and Female
• Exclude criteria: Patients were excluded if they had malignant pleural or pericardial effusion, active double cancer, a concomitant serious illness, such as uncontrolled angina pectoris, myocardial infarction in the previous 3 months, heart failure, uncontrolled diabetes mellitus, uncontrolled hypertension, interstitial pneumonia or lung disease, infection or other diseases contraindicating chemotherapy or radiotherapy, pregnancy, or breast-feeding. Judging of inappropriate condition for this study by physian

Related Information

• Primary Sponsor: Gunma University Hospital
• Source(s) of Monetary Support: None